Publication | Closed Access

Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer

OncologyCancer ManagementPathologyColorectal CancerMetastatic Colorectal CancerPerformance StatusPharmacotherapyIrinotecan-refractory Elderly PatientsMedicineRadiation Oncology